-
公开(公告)号：US20200317648A1
公开(公告)日：2020-10-08
申请号：US16861075
申请日：2020-04-28
Inventor： Daniel J. Canney , Benjamin E. Blass , Rong Gao , Magid Abou-Gharbia
IPC: C07D405/12 , C07D405/06 , C07D307/94 , C07D307/33
Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
-
公开(公告)号：US10544117B2
公开(公告)日：2020-01-28
申请号：US15510152
申请日：2015-09-10
Inventor： Daniel J. Canney , Benjamin E. Blass , Rong Gao , Magid Abou-Gharbia
IPC: C07D405/12 , A61K31/496 , C07D307/33 , C07D307/94 , C07D405/06
Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives of formula (I) having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
-
公开(公告)号：US10239868B2
公开(公告)日：2019-03-26
申请号：US15716752
申请日：2017-09-27
Inventor： Daniel J. Canney , Benjamin E. Blass , Rong Gao , Magid Abou-Gharbia
IPC: C07D405/12 , C07D405/06 , C07D307/94 , C07D307/33
Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
-
公开(公告)号：US12269809B2
公开(公告)日：2025-04-08
申请号：US17517166
申请日：2021-11-02
Inventor： Daniel J. Canney , Benjamin E. Blass , Rong Gao , Magid Abou-Gharbia
IPC: C07D405/06 , C07D307/28 , C07D307/33 , C07D307/94 , C07D405/12 , C07D405/14
Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
-
公开(公告)号：US11897870B2
公开(公告)日：2024-02-13
申请号：US16861075
申请日：2020-04-28
Inventor： Daniel J. Canney , Benjamin E. Blass , Rong Gao , Magid Abou-Gharbia
IPC: C07D405/12 , C07D405/06 , C07D307/94 , C07D307/33
CPC classification number: C07D405/12 , C07D307/33 , C07D307/94 , C07D405/06
Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
-
Patent Agency Ranking
公开(公告)号：US20220306596A1
公开(公告)日：2022-09-29
申请号：US17517166
申请日：2021-11-02
Inventor： Daniel J. Canney , Benjamin E. Blass , Rong Gao , Magid Abou-Gharbia
IPC: C07D307/33 , C07D307/94 , C07D405/06 , C07D405/12 , C07D307/28 , C07D405/14
Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
-
公开(公告)号：US20170298037A1
公开(公告)日：2017-10-19
申请号：US15510152
申请日：2015-09-10
Inventor： Daniel J. Canney , Benjamin E. Blass , Rong Gao , Magid Abou-Gharbia
IPC: C07D307/33 , C07D307/94 , C07D405/06 , C07D405/12
CPC classification number: C07D307/33 , C07D307/28 , C07D307/94 , C07D405/06 , C07D405/12 , C07D405/14
Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
-
公开(公告)号：US20240425487A1
公开(公告)日：2024-12-26
申请号：US18544952
申请日：2023-12-19
Inventor： Daniel J. Canney , Benjamin E. Blass , Rong Gao , Magid Abou-Gharbia
IPC: C07D405/12 , C07D307/33 , C07D307/94 , C07D405/06
Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
-
公开(公告)号：US10676464B2
公开(公告)日：2020-06-09
申请号：US16411534
申请日：2019-05-14
Inventor： Daniel J. Canney , Benjamin E. Blass , Rong Gao , Magid Abou-Gharbia
IPC: C07D405/12 , C07D405/06 , C07D307/94 , C07D307/33
Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
-
公开(公告)号：US10287274B2
公开(公告)日：2019-05-14
申请号：US15716773
申请日：2017-09-27
Inventor： Daniel J. Canney , Benjamin E. Blass , Rong Gao , Magid Abou-Gharbia
IPC: C07D405/12 , C07D405/06 , C07D307/94 , C07D307/33
Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
-
-
-
-
-
-
-
-
-
Search Results
15
records
(took 0.023 seconds)
